A wrong reading could kill someone within hours
In a moment that reveals both the dangers of unchecked technological ambition and the slow, necessary machinery of public protection, the FDA has warned consumers that no wearable device has been authorized to measure blood glucose without piercing the skin — and that products claiming otherwise pose genuine mortal risk. The warning arrives not only as a caution but as a quiet signal to the industry: the path to legitimate non-invasive glucose monitoring exists, but it runs through rigorous regulatory approval. For the millions living with diabetes, this distinction between a trusted reading and a false one is not a matter of convenience — it is a matter of survival.
- Dozens of smartwatches and smart rings are being sold with claims the FDA says are unproven and potentially deadly — no single device has been authorized to measure blood sugar without breaking skin.
- For diabetics, a wrong glucose reading can trigger a catastrophic insulin miscalculation, leading to seizures, coma, or death within hours — the human cost of this market deception is not theoretical.
- Apple and Samsung are both developing non-invasive glucose technology but have not yet released it, and the FDA's warning implicitly maps the only legitimate route to market: seek approval, submit data, prove it works.
- The regulatory line has now been drawn — companies can no longer launch health measurement features on wearables and hope scrutiny never arrives; the FDA is watching and has made its expectations public.
- When a validated glucose sensor eventually reaches a major wearable platform, it will carry something the current fakes cannot offer: accountability, tested accuracy, and the weight of regulatory trust.
The FDA has issued a direct warning to consumers: no smartwatch or smart ring has been authorized to measure blood glucose without drawing blood. Despite this, dozens of companies continue selling such devices under various brand names, each promising non-invasive readings that regulators say simply do not work.
For people living with diabetes, the consequences of trusting a faulty reading are severe. An incorrect glucose number can lead to a wrong insulin dose — too much, and blood sugar can crash dangerously within hours, causing confusion, seizures, coma, or death. The FDA's warning exists because the risk is real and the products are already in people's hands.
Yet the warning carries a second meaning. By drawing attention to what is not approved, the agency is quietly outlining what approval would require. Companies willing to submit data, undergo testing, and seek formal clearance have a path forward. Those hoping to slip through unnoticed do not.
Apple has long been rumored to be developing blood glucose and blood pressure sensors for the Apple Watch, but neither has materialized. Given the company's existing reputation for life-saving health features — heart rhythm detection, fall alerts, blood oxygen monitoring — a glucose sensor would fit naturally into its ecosystem. But it would also demand regulatory blessing before launch, something Apple cannot afford to skip. Samsung is reportedly on a similar trajectory.
When a non-invasive glucose sensor finally arrives on a major wearable platform, it will have passed through the same scrutiny the FDA is now applying to the fakes. That approval won't guarantee perfection — but it will mean the technology was tested, validated, and held accountable. For diabetics whose lives depend on accurate readings, that difference is everything.
The FDA recently issued a stark warning: don't buy smartwatches or smart rings that claim to measure your blood sugar without drawing blood. No skin prick needed, the manufacturers say. No finger stick required. Just wear the device and get your glucose reading. The agency made clear that it has not authorized, cleared, or approved a single wearable device capable of doing this. Yet these products are being sold anyway, often by dozens of companies operating under multiple brand names, each promising the same non-invasive measurement that regulators say doesn't actually work.
For someone living with diabetes, the stakes of this warning are not abstract. An inaccurate blood sugar reading isn't a minor inconvenience—it's a potential medical emergency. If the number on your wrist is wrong, you might take the wrong dose of insulin or other medications designed to lower glucose rapidly. Take too much, and your blood sugar can plummet dangerously within hours. The result can be mental confusion, seizures, coma, or death. The FDA's warning exists because the agency has seen enough concern to feel compelled to speak directly to consumers: these devices cannot be trusted.
But here's the curious thing about this regulatory moment. The warning, while cautionary, also signals something else entirely—a clear pathway forward for companies willing to do the work properly. The FDA is watching the market. It's monitoring which companies are making claims about non-invasive glucose measurement. And implicitly, it's telling the world that if you want to bring such a feature to market legitimately, you will need to seek the agency's guidance and obtain its approval. You cannot simply claim the technology works and hope no one notices.
Apple, notably, is not among the companies currently selling unauthorized glucose-measuring wearables. The company has been rumored for years to be developing both blood pressure and blood glucose sensors for the Apple Watch, but nothing has materialized. The FDA warning, in a strange way, may actually accelerate that timeline by establishing the regulatory framework that Apple and other major technology companies will need to navigate. Apple cannot afford the reputational damage of releasing a health feature that the FDA hasn't cleared, especially one that could directly harm users if it malfunctions. The company's Apple Watch has already built a reputation for potentially life-saving health alerts—detecting irregular heart rhythms, flagging falls, monitoring blood oxygen. A glucose sensor would fit naturally into that ecosystem. But it would also require flawless performance and formal regulatory blessing.
Samsung is reportedly working on similar technology. Other manufacturers are undoubtedly exploring the space. What the FDA warning does is draw a line in the sand: the days of launching health measurement features without regulatory scrutiny are over. Companies will have to prove their devices work before they can claim they do. They'll need to submit data, undergo testing, and wait for approval. It's a slower path than simply releasing a product and seeing what happens. But it's the only path that protects users and preserves the credibility of the technology itself.
When a non-invasive blood glucose sensor finally arrives on an Apple Watch—if it arrives—it will have been through that gauntlet. It will have been tested, validated, and approved by the same agency now warning people away from the fakes. That regulatory stamp won't make the technology perfect. But it will mean something. It will mean someone checked. It will mean the company behind it was willing to be held accountable. For people with diabetes who depend on accurate glucose readings to stay alive, that distinction matters enormously.
Notable Quotes
For people with diabetes, inaccurate blood glucose measurements can lead to errors in diabetes management, including taking the wrong dose of insulin or other medications that can rapidly lower blood glucose.— FDA warning
The Hearth Conversation Another angle on the story
Why does the FDA warning actually give you hope? It seems like bad news—unauthorized devices are out there, people might get hurt.
Because it shows the FDA is paying attention. They're not ignoring the market. They're drawing a line between what's approved and what isn't. That matters for Apple.
How so?
Apple won't launch a glucose sensor without FDA clearance. The company can't risk it. A wrong reading could kill someone. So the warning is the FDA essentially saying: if you want to do this, come through us first.
And Apple will do that?
Almost certainly. Apple has the resources, the credibility, and the incentive. They've built the Apple Watch's reputation on health features that actually work. A glucose sensor would be the crown jewel, but only if it's accurate.
What about the people buying these unauthorized devices right now?
That's the tragedy. They think they're getting a real product. They're not. And for someone with diabetes, that false confidence is dangerous. The FDA warning is trying to stop that.
So this is really about establishing a standard?
Exactly. The warning says: this technology isn't ready yet, at least not from these manufacturers. But it also says: if you do it right, if you get approval, then it can exist. It's drawing the map for how this feature gets built properly.